MIRUM PHARMACEUTICALS INC COM is a security (CUSIP 604749101) tracked across SEC portfolio filings. 324 institutional managers reported $6.1B on Form 13F as of 2026-06-30; 40 registered fund positions totaling $378.2M via N-PORT as of 2026-05-31.
Showing 15 of 324 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | MENLO PARK, CA | $709.4M | 7,679,684 |
| JANUS HENDERSON GROUP PLC | LONDON, X0 | $641.8M | 6,945,813 |
| BlackRock, Inc. | New York, NY | $355.3M | 3,846,530 |
| VANGUARD GROUP INC | Valley Forge, PA | $205.1M | 2,596,089 |
| FMR LLC | BOSTON, MA | $181.6M | 1,965,375 |
| STATE STREET CORP | BOSTON, MA | $179.6M | 1,944,281 |
| BVF INC/IL | San Francisco, CA | $146.4M | 1,584,727 |
| EVENTIDE ASSET MANAGEMENT, LLC | Boston, MA | $130.1M | 1,408,871 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $123.3M | 1,334,809 |
| Novo Holdings A/S | HELLERUP, G7 | $122.4M | 1,325,000 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $116.4M | 1,260,003 |
| TANG CAPITAL MANAGEMENT LLC | SAN DIEGO, CA | $114.2M | 1,236,027 |
| CITADEL ADVISORS LLC | MIAMI, FL | $98.3M | 1,052,048 |
| TCG Crossover Management, LLC | PALO ALTO, CA | $98.1M | 1,062,049 |
| BNP PARIBAS ARBITRAGE, SNC | PARIS, I0 | $84.2M | 911,419 |
Showing 15 of 40 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| SMALLCAP World Fund Inc | SMALLCAP World Fund Inc | $66.9M | 8.26% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $49.2M | 38.56% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $48.7M | 5.98% |
| Janus Henderson Venture Fund | JANUS INVESTMENT FUND | $41.9M | 136.71% |
| LORD ABBETT DEVELOPING GROWTH FUND INC | LORD ABBETT DEVELOPING GROWTH FUND, INC. | $25.6M | 115.40% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $22.0M | 12.54% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $20.8M | 19.08% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $18.5M | 8.50% |
| MFS New Discovery Value Fund | MFS SERIES TRUST XIII | $17.8M | 71.58% |
| Emerald Growth Fund | FINANCIAL INVESTORS TRUST | $10.2M | 72.77% |
| Fidelity Advisor Health Care Fund | Fidelity Advisor Series VII | $9.7M | 33.71% |
| BNY Mellon Research Growth Fund, Inc. | BNY MELLON RESEARCH GROWTH FUND, INC. | $9.0M | 51.76% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $6.2M | 12.93% |
| Fidelity Contrafund | Fidelity Contrafund | $4.2M | 0.27% |
| Small Cap Portfolio | BNY MELLON VARIABLE INVESTMENT FUND | $3.6M | 115.91% |